What To Expect From Boston Scientific’s (BSX) Q2 Earnings

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

BSX Cover Image

Medical device company Boston Scientific (NYSE: BSX) will be reporting earnings this Wednesday morning. Here’s what to expect.

Boston Scientific beat analysts’ revenue expectations last quarter, reporting revenues of $5.20 billion, up 11.6% year on year. It was a softer quarter for the company, with revenue guidance for next quarter missing analysts’ expectations significantly and a miss of analysts’ full-year EPS guidance estimates.

Is Boston Scientific a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Boston Scientific’s revenue to grow 5.9% year on year, slowing from the 22.8% increase it recorded in the same quarter last year.

Boston Scientific Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Boston Scientific has a history of exceeding Wall Street’s expectations.

Looking at Boston Scientific’s peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Abbott Laboratories delivered year-on-year revenue growth of 13%, beating analysts’ expectations by 0.7%, and Intuitive Surgical reported revenues up 18.5%, topping estimates by 2.5%. Abbott Laboratories traded up 12.8% following the results while Intuitive Surgical was down 14.1%.

Read our full analysis of Abbott Laboratories’s results here and Intuitive Surgical’s results here.

Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices up 1.9% on average over the last month. Boston Scientific is up 4.6% during the same time and is heading into earnings with an average analyst price target of $72.25 (compared to the current share price of $45.55).

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.39
+0.00 (0.00%)
AAPL  336.91
+0.00 (0.00%)
AMD  494.95
+0.00 (0.00%)
BAC  62.13
+0.00 (0.00%)
GOOG  326.57
+0.00 (0.00%)
META  593.87
+0.00 (0.00%)
MSFT  389.10
+0.00 (0.00%)
NVDA  196.51
+0.00 (0.00%)
ORCL  119.90
+0.00 (0.00%)
TSLA  309.22
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.